Aristotle University Of Thessaloniki (AUTH)
Μελέτη των υπερηχορρεομετρικών (doppler) δεικτών σε ασθενείς με καρδιακή ανεπάρκεια που αντιμετωπίζονται με νεώτερους φαρμακολογικούς παράγοντες ή βηματοδότηση
Abstract
dc:descriptionThe aim of this clinical study was to examine and compare the efficacy of two intravenously administered inotropic agents, levosimendan and milrinone in acute heart failure vs biventricular implantation measured by hemodynamic parameters and simple markers of cardiac function. The unique aspect of this study is the comparison between the two agents in humans while it has been an effort to provide the possible advantage by using the newer echorrheological indicators, (Tei-index, Z-Ratio, PWLvot x HR). Hemodynamic data are correlated to other measured parameters like BNP and data derived from the Signal Averaged Electrocardiogram. Participants were patients of the Second Department of Cardiology of the Aristotle University of Thessaloniki admitted to the emergency room for acute heart failure, class III or IV according to NYHA classification, without congestion but refractory clinical course with the highest dose of diuretics. They are divided into two main investigational groups: The first group received in addition to the evidence based conventional therapy for acute heart failure, infusion of levosimendan for 48 and up to 72 hours. Simple echocardiographic measurements and data from the Signal Averaged Electrocardiogram were performed at the index point, 48 hours and 72 hours after infusion, respectively. The end-points were divided into primary and secondary: The main primary end-point was defined as the hemodynamic response of each inotrope infusion after 48 or 72 hours according to echocardiographic measurements and the clinical response between the two agents. For the patients with biventricular pacing the same were calculated before implantation, after a month, three months, after six months and after a year. BNP response was not correlated to hemodynamic response. Results derived confirmed the following conclusive points: Infusion of levosimendan or milrinone without a loading dose over 24 up to 72 hours is safe and efficient for immediate clinical improvement. Both levosimendan and milrinone improved haemodynamic response as documented by means of echocardiographic parameters with a supremacy of levosimendan. In acute heart failure, the evaluation of response to the infusion of inotropic agents by means of echocardiographic parameters, is efficient safe and unreplaceble. The application of the newer echorrheological indicators in patients with biventricular pacemaker-defibrilator it was rendered awkward with low reliability. Indexes who estimates the ventricular function globally (PWLvot και PWLvot XHR), provides reliability easyness and reproducibility, estimating the total cardiac performance being able to applicate easily in this particular patients category.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koutsimanis, Vasilios
- Κουτσιμάνης, Βασίλειος
Subjects
dc:subject × 23- Νεώτεροι δείκτες υπερήχων
- Νεώτεροι ινότροποι παράγοντες
- Καρδιακή ανεπάρκεια
- Αμφικοιλιακή βηματοδότηση
- Απινίδωση
- Λεβοσιμενδάνη
- Μιλρινόνη
- Κοιλιακό νατριουρητικό πεπτίδιο
- Newer echorrheological indicators
- Newer inotropic agents
- Heart failure
- Biventricular pacing
- Defibrilation
- Levosimendan
- Milrinone
- Brain natriuretic peptide
- TEI-index
- Z-ratio
- PWVTILVOT
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28082